Hillspire

OurWorlds is an edutainment company creating technologies that empower communities to illuminate their narratives in immersive realities by geolocation in environments throughout the world, in order to inspire transformative new understandings of our collective histories; improve our education system; inform new approaches to environmental stewardship; and reframe a more equitable and just future.

Tierra Biosciences, established in 2015 and based in San Francisco, specializes in developing cell-free technologies for molecule discovery. Its Next Generation Expression platform combines automation, computation, and high-throughput cell-free expression to express DNA from diverse microbial sources, enabling the production of molecules challenging to create using conventional laboratory methods. The company's protein platform integrates cell-free protein production with artificial intelligence, facilitating rapid, large-scale manufacturing akin to e-commerce simplicity. Formerly known as Synvitrobio, Inc., Tierra Biosciences changed its name in September 2018.

Sion Power Corporation, founded in 1989 and based in Tucson, Arizona, specializes in the research, development, and manufacturing of lithium-sulfur rechargeable batteries. The company is recognized as a leader in developing high-energy rechargeable batteries, particularly for applications in electric vehicles, unmanned aerial vehicles, and stationary power markets. Sion Power's innovative Licerion technology significantly enhances battery performance, offering up to 500 Wh/kg energy density, which is twice that of traditional lithium-ion batteries while maintaining the same size and weight. The company also focuses on selling or licensing its proprietary protected lithium anode materials to manufacturers looking to integrate advanced battery solutions into their products. Through its cutting-edge advancements, Sion Power aims to meet the evolving demands of the electric vehicle and aerospace sectors.

Antheia is a biotechnology company focused on harnessing the medicinal power of nature through innovative manufacturing processes. The company employs synthetic biology to overcome traditional drug manufacturing limitations by reconstructing complex molecules in yeast, eliminating the need for medicinal plants. This approach ensures reliable, consistent, and widespread availability of essential medicines. Antheia's methods transform the pharmaceutical supply chain, offering cost-competitive, plant-based medicines that provide healthcare organizations with natural and healthier medication options.